We are live on ! Find out more
APM

Avidity Partners Management Portfolio holdings

AUM $624M Turnover 44.83%
1-Year Est. Return 250.2%
This Fund
S&P 500
This Quarter Est. Return
+45.78%
1 Year Est. Return
+250.2%
3 Year Est. Return
+491.63%
5 Year Est. Return
+985.37%
10 Year Est. Return
–
AUM
$159M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow %
86.65%
Top 10 Hldgs %
52.06%
Holding
33
New
33
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$13.7M
2
HCA icon
HCA Healthcare
HCA
+$8.42M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.1M
4
ABBV icon
AbbVie
ABBV
+$7.8M
5
ZBH icon
Zimmer Biomet
ZBH
+$7.75M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EXAS icon
26
DELISTED
Exact Sciences
EXAS
$2.87M 1.81%
+31,000
New +$2.73M
2019 Q4
0 quarters
NGNE icon
27
Neurogene
NGNE
$471M
$2.59M 1.63%
+10,500
New +$1.05M
2019 Q4
0 quarters
ACAD icon
28
Acadia Pharmaceuticals
ACAD
$3.35B
$2.31M 1.46%
+54,000
New +$2.35M
2019 Q4
0 quarters
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$10.6B
$1.37M 0.86%
+15,000
New +$1.45M
2019 Q4
0 quarters
RCKT icon
30
Rocket Pharmaceuticals
RCKT
$256M
$683K 0.43%
+30,000
New +$501K
2019 Q4
0 quarters
VIRX icon
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$473K 0.3%
+40,000
New +$670K
2019 Q4
0 quarters
ARAV
32
DELISTED
Aravive, Inc. Common Stock
ARAV
$410K 0.26%
+30,000
New +$265K
2019 Q4
0 quarters
RLMD icon
33
Relmada Therapeutics
RLMD
$336M
$390K 0.25%
+10,000
New +$304K
2019 Q4
0 quarters
1
2

Similar funds

ANB
Amarillo National Bank Amarillo, Texas $624M AUM 20.28% 1-Year Est. Return
RIP
RAM Investment Partners Bellevue, Washington $625M AUM 16.29% 1-Year Est. Return
TAM
Third Avenue Management New York $625M AUM 48.93% 1-Year Est. Return
B
Bellecapital Zurich, Switzerland $625M AUM 39.69% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $623M AUM 30.7% 1-Year Est. Return
LWP
LMG Wealth Partners Shreveport, Louisiana $626M AUM 36.27% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $626M AUM 33.6% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $626M AUM 199.29% 1-Year Est. Return

Avidity Partners Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Avidity Partners Management, which disclosed 33 positions worth $159M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Baxter International: 165,000 shares worth $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Avidity Partners Management's largest Q4 2019 buy was Baxter International: 165,000 shares worth $13.8M.
  • Avidity Partners Management's ten largest holdings make up 52% of its $159M portfolio in Q4 2019.
  • Avidity Partners Management disclosed 33 positions in Q4 2019, its first 13F filing on record.

Based on Avidity Partners Management's 13F filing for Q4 2019, filed 14 Feb 2020.